Sector: MedicalPeregrine Pharmaceuticals Inc. (NASDAQ: PPHM)
Headlines
- Briefs: SPNGE, PPHM
Oct 20, 2009 10:31 AM | PPHM
- Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
Oct 19, 2009 09:30 AM | PPHM
- Peregrine Pharmaceuticals 1:5 Reverse Stock Split Takes Effect
Oct 19, 2009 08:31 AM | PPHM
- Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
Oct 16, 2009 03:00 PM | PPHM
- Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
Oct 07, 2009 09:40 AM | PPHM
- Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
Oct 05, 2009 08:03 AM | PPHM
- Avid Bioservices Becomes U.S. West Coast Partner of Boehringer Ingelheim's Global Production Alliance Network for Biologic Contract Manufacturing Services
Sep 21, 2009 09:31 AM | PPHM
- Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
Sep 08, 2009 09:40 AM | PPHM
- Small-Cap Stocks Battling Brain Cancer
Sep 07, 2009 08:07 PM | EXEL, PFE, PPHM
- Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
Sep 03, 2009 07:01 AM | PPHM
- Peregrine Pharmaceuticals to Report First Quarter FY 2010 Financial Results
Aug 27, 2009 08:01 AM | PPHM
- NIAID Awards New Grant to Expand Studies of Peregrine's Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
Aug 26, 2009 08:01 AM | PPHM
- Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference
Jul 23, 2009 08:02 AM | PPHM
- Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
Jul 22, 2009 09:03 AM | PPHM
- Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Jul 14, 2009 07:02 AM | PPHM
- Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Jul 13, 2009 08:31 AM | ACCP, CYTX, ECTE, JLI, NABI
- BenchmarkJournal.Com Free Analyst Review for GAP, ATU, PPHM, MNKD, HLIT and COCO
Jul 02, 2009 10:21 AM | ATU, COCO, GAP, HLIT, MNKD, PPHM
- Peregrine Pharmaceuticals to Report Fiscal Year 2009 Financial Results
Jul 02, 2009 07:30 AM | PPHM
- Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine
Jul 01, 2009 08:02 AM | PPHM
- Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
Jun 30, 2009 09:02 AM | PPHM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
PPHM
|
Compare to S&P
|
| YTD |
120.69 %
|
83.27 %
|
| 4 Weeks |
-12.33 %
|
-13.89 %
|
| 12 Weeks |
-16.88 %
|
-25.17 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 50.00 %
|
|
EPS Growth in Last Year: 50.00 %
|
|
Sales Growth in Last Quarter: -14.20 %
|
|
Sales Growth in Last Quarter: 344.96 %
|
|
